LOS ANGELES--(BUSINESS WIRE)--C3 Jian, Inc., a privately-held clinical stage biotechnology company focused on the development and commercialization of novel therapeutics aimed at reengineering the human microbiome, announced that H. Stewart Parker has been appointed as new Chair of the Board of Directors, effective immediately. The Company’s former and Founding Chairman, Mr. Jim Garrison, will remain an active member of the Board.
